The Europe Large Molecule Drug Substance CDMO Market would witness market growth of 8.4% CAGR during the forecast period (2022-2028).
In the pharmaceutical sector, biologics are currently emerging as a therapeutic molecules’ next-generation. The large size and complexity of biologics forbid their production through existing methods. Instead, biologics are mostly recombinantly synthesized by engineered cells. Biologics pharmaceuticals or biopharmaceuticals bind to cells externally to induce the needed cellular response.
Additionally, since biologics can perform target-specific cellular binding, their interference with healthy cells becomes negligible, eventually increasing the use of these drugs. CDMOs are preferred for large molecules as these kinds of molecules are produced through complex steps, often over 1000. Biologics work by moving drugs to targeted locations in the body without releasing them before the specified location.
Large molecule drugs are mostly given as infusions or injections as they are ineffective when consumed orally. Vaccines, blood components, blood, tissue, gene therapy, and some proteins primarily constitute large molecule drug substances. In the past few years, research regarding the development of large molecule drugs has been rising rapidly as they have the potential to offer medications for medical conditions that have no other treatment alternative.
The rising disease burden prevalence has propelled biopharmaceutical firms to develop efficient drugs to tackle the increasing number of heart disorders. The region's governments are also specifying laws that would aid in the manufacture and approval of many drugs. For example, an expansive list of available guidelines and opportunities for the involvement of CDMOs during the development stage of a medicinal product has been formed by European Medicines Agency (EMA).
The Germany market dominated the Europe Large Molecule Drug Substance CDMO Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,216.8 million by 2028. The UK market is anticipated to grow at a CAGR of 7.5% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 9.2% during (2022 - 2028).
Based on Application, the market is segmented into Mammalian, Microbial and Others. Based on Service, the market is segmented into Contract Manufacturing and Contract Development. Based on Contract Manufacturing Type, the market is segmented into Commercial and Clinical. Based on Contract Development Type, the market is segmented into Cell Line Development and Process Development. Based on End-user, the market is segmented into Biotech Companies, CRO and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Large Molecule Drug Substance CDMO Market will Hit $19.2 Billion by 2028, at a CAGR of 8.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eurofins Scientific SE, WuXi Biologics (Cayman), Inc, Catalent, Inc., Boehringer Ingelheim International GmbH, FUJIFILM Diosynth Biotechnologies Texas LLC (Fujifilm Corporation), Samsung Biologics Co., Ltd. (Samsung Group), Rentschler Biopharma SE, AGC Biologics, Inc. (AGC, Inc.), Recipharm AB (EQT AB), and Siegfried Holding AG.
Scope of the Study
Market Segments Covered in the Report:
By Application
By Service
- Contract Manufacturing
- Contract Development
- Cell Line Development
- Process Development
By End-user
- Biotech Companies
- CRO
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Eurofins Scientific SE
- WuXi Biologics (Cayman), Inc
- Catalent, Inc.
- Boehringer Ingelheim International GmbH
- FUJIFILM Diosynth Biotechnologies Texas LLC (Fujifilm Corporation)
- Samsung Biologics Co., Ltd. (Samsung Group)
- Rentschler Biopharma SE
- AGC Biologics, Inc. (AGC, Inc.)
- Recipharm AB (EQT AB)
- Siegfried Holding AG
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Large Molecule Drug Substance CDMO Market, by Application
1.4.2 Europe Large Molecule Drug Substance CDMO Market, by Service
1.4.3 Europe Large Molecule Drug Substance CDMO Market, by End-user
1.4.4 Europe Large Molecule Drug Substance CDMO Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Acquisition and Mergers
3.2.3 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Apr– 2022, Oct) Leading Players
3.3.3 Key Strategic Move: (Acquisitions and Mergers : 2018, Oct – 2022, Aug) Leading Players
Chapter 4. Europe Large Molecule Drug Substance CDMO Market by Application
4.1 Europe Mammalian Market by Country
4.2 Europe Microbial Market by Country
4.3 Europe Other Application Market by Country
Chapter 5. Europe Large Molecule Drug Substance CDMO Market by Service
5.1 Europe Contract Manufacturing Market by Country
5.2 Europe Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
5.2.1 Europe Commercial Market by Country
5.2.2 Europe Clinical Market by Country
5.3 Europe Contract Development Market by Country
5.4 Europe Large Molecule Drug Substance CDMO Market by Contract Development Type
5.4.1 Europe Cell Line Development Market by Country
5.4.2 Europe Process Development Market by Country
Chapter 6. Europe Large Molecule Drug Substance CDMO Market by End-user
6.1 Europe Biotech Companies Market by Country
6.2 Europe CRO Market by Country
6.3 Europe Others Market by Country
Chapter 7. Europe Large Molecule Drug Substance CDMO Market by Country
7.1 Germany Large Molecule Drug Substance CDMO Market
7.1.1 Germany Large Molecule Drug Substance CDMO Market by Application
7.1.2 Germany Large Molecule Drug Substance CDMO Market by Service
7.1.2.1 Germany Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.1.2.2 Germany Large Molecule Drug Substance CDMO Market by Contract Development Type
7.1.3 Germany Large Molecule Drug Substance CDMO Market by End-user
7.2 UK Large Molecule Drug Substance CDMO Market
7.2.1 UK Large Molecule Drug Substance CDMO Market by Application
7.2.2 UK Large Molecule Drug Substance CDMO Market by Service
7.2.2.1 UK Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.2.2.2 UK Large Molecule Drug Substance CDMO Market by Contract Development Type
7.2.3 UK Large Molecule Drug Substance CDMO Market by End-user
7.3 France Large Molecule Drug Substance CDMO Market
7.3.1 France Large Molecule Drug Substance CDMO Market by Application
7.3.2 France Large Molecule Drug Substance CDMO Market by Service
7.3.2.1 France Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.3.2.2 France Large Molecule Drug Substance CDMO Market by Contract Development Type
7.3.3 France Large Molecule Drug Substance CDMO Market by End-user
7.4 Russia Large Molecule Drug Substance CDMO Market
7.4.1 Russia Large Molecule Drug Substance CDMO Market by Application
7.4.2 Russia Large Molecule Drug Substance CDMO Market by Service
7.4.2.1 Russia Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.4.2.2 Russia Large Molecule Drug Substance CDMO Market by Contract Development Type
7.4.3 Russia Large Molecule Drug Substance CDMO Market by End-user
7.5 Spain Large Molecule Drug Substance CDMO Market
7.5.1 Spain Large Molecule Drug Substance CDMO Market by Application
7.5.2 Spain Large Molecule Drug Substance CDMO Market by Service
7.5.2.1 Spain Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.5.2.2 Spain Large Molecule Drug Substance CDMO Market by Contract Development Type
7.5.3 Spain Large Molecule Drug Substance CDMO Market by End-user
7.6 Italy Large Molecule Drug Substance CDMO Market
7.6.1 Italy Large Molecule Drug Substance CDMO Market by Application
7.6.2 Italy Large Molecule Drug Substance CDMO Market by Service
7.6.2.1 Italy Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.6.2.2 Italy Large Molecule Drug Substance CDMO Market by Contract Development Type
7.6.3 Italy Large Molecule Drug Substance CDMO Market by End-user
7.7 Rest of Europe Large Molecule Drug Substance CDMO Market
7.7.1 Rest of Europe Large Molecule Drug Substance CDMO Market by Application
7.7.2 Rest of Europe Large Molecule Drug Substance CDMO Market by Service
7.7.2.1 Rest of Europe Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.7.2.2 Rest of Europe Large Molecule Drug Substance CDMO Market by Contract Development Type
7.7.3 Rest of Europe Large Molecule Drug Substance CDMO Market by End-user
Chapter 8. Company Profiles
8.1 Teledyne FLIR LLC (Teledyne Technologies Incorporated)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Recent strategies and developments:
8.1.4.1 Partnerships, Collaborations and Agreements:
8.1.4.2 Product Launches and Product Expansions:
8.1.5 SWOT Analysis
8.2 Hikvision Digital Technology Co., Ltd., (China Electronics Technology Group Corporation)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Research & Development Expenses
8.2.4 Recent strategies and developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.2.4.2 Product Launches and Product Expansions:
8.3 Axis Communications AB (Canon, Inc.)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 Bosch Security Systems GmbH (Robert Bosch GmbH)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 Avigilon Corporation (Motorola Solutions)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional & Segmental Analysis
8.5.4 Research & Development Expenses
8.6 Hanwha Techwin Co., Ltd. (Hanwha Group)
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.6.2.2 Product Launches and Product Expansions:
8.7 Zhejiang Dahua Technology Co., Ltd.
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Zhejiang Uniview Technologies Co., Ltd. (Hangzhou Jiaozhi Technology Co., Ltd.)
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
TABLE 1 Europe Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 2 Europe Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Large Molecule Drug Substance CDMO Market
TABLE 4 Acquisition and Mergers– Large Molecule Drug Substance CDMO Market
TABLE 5 Geographical Expansions – Large Molecule Drug Substance CDMO Market
TABLE 6 Europe Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 7 Europe Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 8 Europe Mammalian Market by Country, 2018 - 2021, USD Million
TABLE 9 Europe Mammalian Market by Country, 2022 - 2028, USD Million
TABLE 10 Europe Microbial Market by Country, 2018 - 2021, USD Million
TABLE 11 Europe Microbial Market by Country, 2022 - 2028, USD Million
TABLE 12 Europe Other Application Market by Country, 2018 - 2021, USD Million
TABLE 13 Europe Other Application Market by Country, 2022 - 2028, USD Million
TABLE 14 Europe Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 15 Europe Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 16 Europe Contract Manufacturing Market by Country, 2018 - 2021, USD Million
TABLE 17 Europe Contract Manufacturing Market by Country, 2022 - 2028, USD Million
TABLE 18 Europe Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 19 Europe Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 20 Europe Commercial Market by Country, 2018 - 2021, USD Million
TABLE 21 Europe Commercial Market by Country, 2022 - 2028, USD Million
TABLE 22 Europe Clinical Market by Country, 2018 - 2021, USD Million
TABLE 23 Europe Clinical Market by Country, 2022 - 2028, USD Million
TABLE 24 Europe Contract Development Market by Country, 2018 - 2021, USD Million
TABLE 25 Europe Contract Development Market by Country, 2022 - 2028, USD Million
TABLE 26 Europe Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 27 Europe Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 28 Europe Cell Line Development Market by Country, 2018 - 2021, USD Million
TABLE 29 Europe Cell Line Development Market by Country, 2022 - 2028, USD Million
TABLE 30 Europe Process Development Market by Country, 2018 - 2021, USD Million
TABLE 31 Europe Process Development Market by Country, 2022 - 2028, USD Million
TABLE 32 Europe Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 33 Europe Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 34 Europe Biotech Companies Market by Country, 2018 - 2021, USD Million
TABLE 35 Europe Biotech Companies Market by Country, 2022 - 2028, USD Million
TABLE 36 Europe CRO Market by Country, 2018 - 2021, USD Million
TABLE 37 Europe CRO Market by Country, 2022 - 2028, USD Million
TABLE 38 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 39 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 40 Europe Large Molecule Drug Substance CDMO Market by Country, 2018 - 2021, USD Million
TABLE 41 Europe Large Molecule Drug Substance CDMO Market by Country, 2022 - 2028, USD Million
TABLE 42 Germany Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 43 Germany Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 44 Germany Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 45 Germany Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 46 Germany Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 47 Germany Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 48 Germany Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 49 Germany Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 50 Germany Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 51 Germany Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 52 Germany Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 53 Germany Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 54 UK Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 55 UK Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 56 UK Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 57 UK Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 58 UK Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 59 UK Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 60 UK Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 61 UK Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 62 UK Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 63 UK Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 64 UK Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 65 UK Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 66 France Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 67 France Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 68 France Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 69 France Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 70 France Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 71 France Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 72 France Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 73 France Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 74 France Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 75 France Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 76 France Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 77 France Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 78 Russia Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 79 Russia Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 80 Russia Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 81 Russia Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 82 Russia Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 83 Russia Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 84 Russia Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 85 Russia Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 86 Russia Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 87 Russia Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 88 Russia Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 89 Russia Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 90 Spain Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 91 Spain Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 92 Spain Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 93 Spain Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 94 Spain Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 95 Spain Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 96 Spain Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 97 Spain Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 98 Spain Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 99 Spain Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 100 Spain Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 101 Spain Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 102 Italy Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 103 Italy Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 104 Italy Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 105 Italy Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 106 Italy Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 107 Italy Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 108 Italy Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 109 Italy Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 110 Italy Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 111 Italy Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 112 Italy Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 113 Italy Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 114 Rest of Europe Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 115 Rest of Europe Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 116 Rest of Europe Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 117 Rest of Europe Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 118 Rest of Europe Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 119 Rest of Europe Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 120 Rest of Europe Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 121 Rest of Europe Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 122 Rest of Europe Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 123 Rest of Europe Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 124 Rest of Europe Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 125 Rest of Europe Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 126 Key Information – Teledyne FLIR LLC
TABLE 127 Key Information – Hikvision Digital Technology Co., Ltd.,
TABLE 128 Key Information – Axis Communications AB
TABLE 129 Key Information – Bosch Security Systems GmbH
TABLE 130 Key Information – Avigilon Corporation
TABLE 131 Key Information – Hanwha Techwin Co., Ltd.
TABLE 132 Key Information – Zhejiang Dahua Technology Co., Ltd.
TABLE 133 Key Information – Zhejiang Uniview Technologies Co., Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, APR – 2022, Oct) Leading Players
FIG 5 Key Strategic Move: (Acquisitions and Mergers : 2018, Oct – 2022, Aug) Leading Players
FIG 6 Recent strategies and developments: Teledyne FLIR LLC
FIG 7 Swot analysis: Teledyne FLIR LLC
FIG 8 Recent strategies and developments: Hikvision Digital Technology Co., Ltd.
FIG 9 Recent strategies and developments: Axis Communications AB
FIG 10 Recent strategies and developments: Hanwha Techwin Co., Ltd.